glp 1 agonists drug class GLP-1 for Weight Loss: Safe or Risky? Upcoming wave of hormone-based therapies
Description
Some trials including latestage studies of oral semaglutide did not show a meaningful slowing of memory decline or disease progression compared with placebo
NOTES None Acknowledgements Fig
Until next time, Dr
Personal or family history of medullary thyroid carcinoma represents an absolute contraindication
Zaharia, O
